A fair growth of 10.79% in the revenue at Rs. 119.05 millions was reported in the December 2022 quarter as compared to Rs. 107.46 millions during year-ago period.The Net Loss for the quarter ended December 2022 is Rs. -0.04 millions as compared to Net Profit of Rs. 4.78 millions of corresponding quarter ended December 2021A decline of 2.04 millions was observed in the OP in the quarter ended December 2022 from 7.12 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 119.05 107.46 10.79 338.94 308.09 10.01 401.34 251.78 59.40
Other Income 0.84 0.70 20.00 2.53 2.13 18.78 3.06 8.02 -61.85
PBIDT 2.04 7.12 -71.35 -17.14 30.23 -156.70 14.24 -19.66 -172.43
Interest 1.39 1.03 34.95 5.55 2.55 117.65 4.01 3.89 3.08
PBDT 0.65 6.09 -89.33 -22.69 27.68 -181.97 10.23 -23.55 -143.44
Depreciation 0.69 0.56 23.21 2.07 1.60 29.37 2.76 1.76 56.82
PBT -0.04 5.53 -100.72 -24.76 26.08 -194.94 7.47 -25.31 -129.51
TAX 0.00 0.75 0.00 0.00 0.75 0.00 -1.26 -0.11 1045.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
PAT -0.04 4.78 -100.84 -24.76 25.33 -197.75 8.73 -25.20 -134.64
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 1.71 6.63 -74.14 -5.06 9.81 -151.54 3.55 -7.81 -145.44

Guj. Terce Lab Share Price

79.00 -1.58 (-1.96%)
22-Nov-2024 13:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1780.95
Dr. Reddys Lab 1211.95
Cipla 1486.30
Lupin 2064.75
Zydus Lifesciences 947.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.